Tom Roseberry
About Tom Roseberry
Tom Roseberry CTO and Co-Founder
Tom Roseberry is the Co-Founder and Chief Technology Officer (CTO) with more than 15 years of industry experience. Throughout his career, he has built and led teams and developed cutting-edge technologies in various fields, including aerospace, brain-machine interfacing, synthetic biology, and drug discovery and development. His extensive background highlights his role as a key innovator in multiple high-tech industries.
Tom Roseberry at Neuralink
At Neuralink, Tom Roseberry played a pivotal role in advancing neural interface technology. He co-led the group responsible for developing and prototyping the next-generation neural interface. This involved spearheading research and development efforts that aimed at making significant strides in brain-machine interfacing technology. His contributions have been integral to propelling Neuralink's technological advancements forward.
Tom Roseberry’s Role at Loyal
Tom Roseberry served as the Vice President of Engineering, Computational Biology and Drug Development at Loyal. In this position, he directed multiple groups to execute the largest ever epigenetic study in dogs. Additionally, he was instrumental in developing the final formulation of Loyal’s lead molecule and was the architect behind the statistical plan for the first ever lifespan extension pivotal study. His leadership and expertise were central to advancing Loyal's research and development initiatives.
Tom Roseberry's Industry Collaborations and Partnerships
Throughout his career, Tom Roseberry has successfully led multiple partnerships with established institutions and companies. These collaborations have been essential in fostering innovation and advancing technological development across various high-tech and biotech fields. His ability to bridge relationships between different entities has underscored his role as a key player in driving industry-wide progress.
Tom Roseberry Patents
Tom Roseberry holds several patents related to his groundbreaking work in multiple fields. His patented innovations span areas such as brain-machine interfacing, synthetic biology, and drug discovery. These patents are a testament to his contributions and advancements in technology and biotechnology, offering tangible proof of his impact and expertise in these sectors.